- Home
- NTRB vs UCL Comparison
NTRB vs UCL Comparison
Compare NTRB & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- UCL
- Stock Information
- Founded
- NTRB 2016
- UCL 2014
- Country
- NTRB United States
- UCL Hong Kong
- Employees
- NTRB N/A
- UCL N/A
- Industry
- NTRB Industrial Specialties
- UCL Telecommunications Equipment
- Sector
- NTRB Health Care
- UCL Consumer Discretionary
- Exchange
- NTRB Nasdaq
- UCL Nasdaq
- Market Cap
- NTRB 59.1M
- UCL 70.6M
- IPO Year
- NTRB N/A
- UCL 2020
- Fundamental
- Price
- NTRB $9.91
- UCL $1.83
- Analyst Decision
- NTRB Buy
- UCL
- Analyst Count
- NTRB 1
- UCL 0
- Target Price
- NTRB $13.00
- UCL N/A
- AVG Volume (30 Days)
- NTRB 126.8K
- UCL 59.0K
- Earning Date
- NTRB 05-30-2025
- UCL 08-13-2025
- Dividend Yield
- NTRB N/A
- UCL N/A
- EPS Growth
- NTRB N/A
- UCL N/A
- EPS
- NTRB N/A
- UCL 0.09
- Revenue
- NTRB $2,398,437.00
- UCL $92,256,000.00
- Revenue This Year
- NTRB $560.75
- UCL $6.09
- Revenue Next Year
- NTRB $588.39
- UCL $7.01
- P/E Ratio
- NTRB N/A
- UCL $19.62
- Revenue Growth
- NTRB 18.92
- UCL 7.65
- 52 Week Low
- NTRB $3.72
- UCL $0.80
- 52 Week High
- NTRB $11.78
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- NTRB 69.95
- UCL 54.00
- Support Level
- NTRB $7.52
- UCL $1.79
- Resistance Level
- NTRB $11.68
- UCL $1.99
- Average True Range (ATR)
- NTRB 0.67
- UCL 0.16
- MACD
- NTRB 0.19
- UCL -0.03
- Stochastic Oscillator
- NTRB 62.19
- UCL 19.05
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.